Germacrone cooperates with dexmedetomidine to alleviate high‑fat diet‑induced type 2 diabetes mellitus via upregulating AMPKα1 expression

Yang Sun, Lanlan Li, Jun Wu, Bing Gong, Haiyan Liu

Open source

DOI
10.3892/etm.2019.7990
Published
2019-09-09
Container
Experimental and Therapeutic Medicine
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/etm.2019.7990,
  title = {Germacrone cooperates with dexmedetomidine to alleviate high‑fat diet‑induced type 2 diabetes mellitus via upregulating AMPKα1 expression},
  author = {Yang Sun and Lanlan Li and Jun Wu and Bing Gong and Haiyan Liu},
  year = {2019},
  journal = {Experimental and Therapeutic Medicine},
  doi = {10.3892/etm.2019.7990},
  url = {https://doi.org/10.3892/etm.2019.7990}
}

RIS

TY  - JOUR
TI  - Germacrone cooperates with dexmedetomidine to alleviate high‑fat diet‑induced type 2 diabetes mellitus via upregulating AMPKα1 expression
AU  - Yang Sun
AU  - Lanlan Li
AU  - Jun Wu
AU  - Bing Gong
AU  - Haiyan Liu
PY  - 2019
JO  - Experimental and Therapeutic Medicine
DO  - 10.3892/etm.2019.7990
UR  - https://doi.org/10.3892/etm.2019.7990
ER  - 

APA

Sun, Y., Li, L., Wu, J., Gong, B., & Liu, H. (2019). Germacrone cooperates with dexmedetomidine to alleviate high‑fat diet‑induced type 2 diabetes mellitus via upregulating AMPKα1 expression. Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2019.7990

Source records